78 lines
2.8 KiB
JSON
78 lines
2.8 KiB
JSON
{
|
|
"study": "77242113UCO3001",
|
|
"report_id": 92,
|
|
"forms": [
|
|
"Acknowledgement Reporting Form",
|
|
"Acknowledgement Upload Form",
|
|
"Additional Liver Event Assessment Forms",
|
|
"Advanced Therapy Treatment Failure Reason",
|
|
"Adverse Events/Serious AEs",
|
|
"Alcohol Consumption",
|
|
"Axial Spondyloarthropathy Diagnosis Information",
|
|
"Clinical Outcome Assessments Completion Status",
|
|
"Concomitant Therapy",
|
|
"Consents / Withdrawal of Consents for Optional Research",
|
|
"Corticosteroid, Immunomodulator And Oral Aminosalicylates History",
|
|
"Date of Visit",
|
|
"Death Information",
|
|
"Demographics",
|
|
"Derivation (operational form)",
|
|
"DSL Index Page (Must have for DSL functionality; not visible to the sites) (operational form)",
|
|
"DUMMY (operational form)",
|
|
"Endoscopy Information",
|
|
"Enrollment",
|
|
"Family History specific to Hepatic Event",
|
|
"Food/Liquid Fasting Compliance",
|
|
"General Medical History",
|
|
"GI Related Surgeries and Procedures",
|
|
"Group Selection",
|
|
"Hepatic Event - Other Risk Factors",
|
|
"History of GI Past Related Surgeries/Procedures",
|
|
"Inclusion/Exclusion Criteria",
|
|
"Integrated Medication Kit Accountability Information",
|
|
"Interim Investigator Signature",
|
|
"Intestinal Ultrasound",
|
|
"Limitation on Retention of Samples",
|
|
"Liver Biopsy",
|
|
"Liver Chemistry Abnormalities Assessment Form",
|
|
"Liver Event Case of AEs",
|
|
"Liver Event Chemistry Analytes",
|
|
"Liver Event Level 1 Analytes",
|
|
"Liver Event Level 2 Analytes",
|
|
"Liver Event Workup Completion Status",
|
|
"Liver Imaging Assessment",
|
|
"Liver-related Signs and Symptoms of Hypersensitivity",
|
|
"Liver-related Signs and Symptoms of Liver Injury",
|
|
"Medical Encounters",
|
|
"Medical History: Liver-related Diseases",
|
|
"Periodic Investigator's EDC Review Acknowledgement",
|
|
"Pharmacokinetics, Pharmacodynamic and Biomarker Sample Collection",
|
|
"Preplanned Surgeries/Procedures",
|
|
"Protocol Amendment Implementation (Operational Form)",
|
|
"Randomization",
|
|
"Relevant Additional Drug Therapies",
|
|
"Relevant Information Selection",
|
|
"Relevant Local Laboratory",
|
|
"Relevant Local Laboratory Data",
|
|
"Relevant Procedures",
|
|
"Relevant Study Medication",
|
|
"Relevant Tests",
|
|
"Safety Report Form",
|
|
"Screening for Tuberculosis",
|
|
"Site/Invest Identification",
|
|
"Study Drug Administration",
|
|
"Subject",
|
|
"Subject Site Switch",
|
|
"Substance Use Alcohol",
|
|
"Substance Use Tobacco/Nicotine",
|
|
"Treatment Disposition (End of treatment)",
|
|
"Treatment Unblinding",
|
|
"Trial Disposition (Completion / Discontinuation)",
|
|
"Tuberculosis Testing and Results",
|
|
"Ulcerative Colitis Disease History",
|
|
"Ulcerative Colitis Medication History",
|
|
"Unscheduled Assessments",
|
|
"Vital Signs"
|
|
]
|
|
}
|